Number Of In Process Research And Development Projects Acquired

No definition available.

Name:	endp_NumberOfInProcessResearchAndDevelopmentProjectsAcquired
Namespace Prefix:	endp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Product Licenses

+ References

No definition available.

+ Details

Name:	endp_NumberOfProductLicenses
Namespace Prefix:	endp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number Of Product Licenses Revoked

+ References

No definition available.

+ Details

Name:	endp_NumberOfProductLicensesRevoked
Namespace Prefix:	endp_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=endp_NevakarInjectablesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=endp_TLCAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

LICENSE, COLLABORATION AND ASSET ACQUISITION AGREEMENTS - Narrative (Details) $ in Millions	1 Months Ended		3 Months Ended
	Aug. 31, 2022 product	May 31, 2022 USD ($) project	Jun. 30, 2022 USD ($)
Nevakar Injectables, Inc
Collaborative Arrangement and Arrangement Other than Collaborative
Number of in process research and development projects acquired \| project		6
Acquired in-process research and development \| $		$ 35.0
Number of product licenses revoked (product) \| product	2
Number of product licenses (product) \| product	3
TLC Agreement
Collaborative Arrangement and Arrangement Other than Collaborative
Acquired in-process research and development \| $			$ 30.0